{"id":409755,"date":"2021-01-06T13:17:49","date_gmt":"2021-01-06T18:17:49","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409755"},"modified":"2021-01-06T13:17:49","modified_gmt":"2021-01-06T18:17:49","slug":"lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/","title":{"rendered":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments"},"content":{"rendered":"
\n

VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and treatments for SARS-CoV-2, i.e., COVID-19. In particular, the scientific literature, online media reports and survey portals from various countries will be reviewed to determine their effects, especially in seniors. COVID-19 is known to affect the body\u2019s clotting and inflammatory processes, which may lead to an increased risk of blood clots and lung inflammation. Seniors are most prone to this virus and therefore there is a need to know if vaccines such as the ones developed by Pfizer\/BioNTech and Moderna do indeed protect the population and if treatments such as heparin do indeed reduce disease severity, in particular in patients residing in the ICU and those with \u2018long COVID\u2019 effects (i.e., post-COVID-19 infection). This information can be useful for seniors and families living in long term care and assisted living who need to deal with advanced care planning and end-of-life issues. The data will also help administrators prepare policies that make sense for future pandemics. According to Lui Franciosi, \u2018This scientific review will be eventually published for seniors, families and the general public to consider.\u2019<\/p>\n

For more information about Lui Franciosi and his company Franciosi Consulting Ltd., please visit https:\/\/franciosiconsulting.com\/<\/a> or his YouTube Channel https:\/\/www.youtube.com\/channel\/UC7PSoeH8yN-HuLg5xFi5Qxw\/<\/a>. Dr. Franciosi advises on the operational and research needs of the pharmaceutical and senior care industries. He also discusses topics online such as running your own business, chronic pain, the importance of senior care, Lyme Disease, as well as COVID-19 & the Pfizer\/BioNTech and Moderna vaccines.<\/p>\n

\n About Lui Franciosi<\/strong>\n <\/p>\n

Lui Franciosi is a pharmacologist and consultant with over 20 years of executive experience collected in the pharmaceutical and senior care industries. He holds a Masters degree and a Doctorate from the University of British Columbia in Vancouver. He also studied business at the University of Warwick in the U.K. Lui Franciosi founded Franciosi Consulting Ltd. in 2015 and is the president and CEO.<\/p>\n

\n Contact<\/strong>
\n
\n lui@franciosiconsulting.com<\/a>
\n
+1.778.998.6260<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and treatments for SARS-CoV-2, i.e., COVID-19. In particular, the scientific literature, online media reports and survey portals from various countries will be reviewed to determine their effects, especially in seniors. COVID-19 is known to affect the body\u2019s clotting and inflammatory processes, which may lead to an increased risk of blood clots and lung inflammation. Seniors are most prone to this virus and therefore there is a need to know if vaccines such as the ones developed by Pfizer\/BioNTech and Moderna do indeed protect the population and if treatments such as heparin do … <\/p>\n

Continue reading “Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409755","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and treatments for SARS-CoV-2, i.e., COVID-19. In particular, the scientific literature, online media reports and survey portals from various countries will be reviewed to determine their effects, especially in seniors. COVID-19 is known to affect the body\u2019s clotting and inflammatory processes, which may lead to an increased risk of blood clots and lung inflammation. Seniors are most prone to this virus and therefore there is a need to know if vaccines such as the ones developed by Pfizer\/BioNTech and Moderna do indeed protect the population and if treatments such as heparin do … Continue reading "Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T18:17:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments\",\"datePublished\":\"2021-01-06T18:17:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/\"},\"wordCount\":366,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/\",\"name\":\"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=\",\"datePublished\":\"2021-01-06T18:17:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/","og_locale":"en_US","og_type":"article","og_title":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk","og_description":"VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) — Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and treatments for SARS-CoV-2, i.e., COVID-19. In particular, the scientific literature, online media reports and survey portals from various countries will be reviewed to determine their effects, especially in seniors. COVID-19 is known to affect the body\u2019s clotting and inflammatory processes, which may lead to an increased risk of blood clots and lung inflammation. Seniors are most prone to this virus and therefore there is a need to know if vaccines such as the ones developed by Pfizer\/BioNTech and Moderna do indeed protect the population and if treatments such as heparin do … Continue reading \"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T18:17:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments","datePublished":"2021-01-06T18:17:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/"},"wordCount":366,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/","name":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=","datePublished":"2021-01-06T18:17:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY3NiMzOTA3NDkxIzIxOTQwNjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lui-franciosi-to-monitor-the-safety-and-efficacy-of-covid-19-vaccines-and-treatments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409755"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409755\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}